{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:29:14Z","timestamp":1790778554842,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093283","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:05:13Z","timestamp":1396040713000},"page":"e93283","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mouse Models of Anemia of Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Airie","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Shprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Limbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Gabayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"K Knight","year":"2004","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2005.08.004","article-title":"Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?","volume":"50","author":"P Kosmidis","year":"2005","journal-title":"Lung Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.10763","article-title":"Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy","volume":"95","author":"J Crawford","year":"2002","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/cncr.11742","article-title":"Cancer-related fatigue: evolving concepts in evaluation and treatment","volume":"98","author":"R Stasi","year":"2003","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"JJ Caro","year":"2001","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"vii167","DOI":"10.1093\/annonc\/mdq284","article-title":"Anemia in cancer","volume":"21","author":"M Dicato","year":"2010","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/1078-0432.CCR-07-4153","article-title":"Involvement of hepcidin in the anemia of multiple myeloma","volume":"14","author":"S Sharma","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref8","first-page":"159","article-title":"The anemia of inflammation\/malignancy: mechanisms and management","author":"JW Adamson","year":"2008","journal-title":"Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"G Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"CH Park","year":"2001","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"T Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"E Nemeth","year":"2004","journal-title":"Science"},{"key":"ref13","first-page":"1271","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"E Nemeth","year":"2004","journal-title":"J ClinInvest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6 induces hepcidin expression through STAT3","volume":"108","author":"DM Wrighting","year":"2006","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.gastro.2006.10.018","article-title":"STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo","volume":"132","author":"A Pietrangelo","year":"2007","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2006-07-033969","article-title":"STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation","volume":"109","author":"MV Verga Falzacappa","year":"2007","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/030089160409000207","article-title":"Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer","volume":"90","author":"N Songur","year":"2004","journal-title":"Tumori"},{"key":"ref18","first-page":"210","article-title":"[Changes of serum il-6 and CRP after chemotherapy in patients with ovarian carcinoma]","volume":"11","author":"I Zakrzewska","year":"2001","journal-title":"Pol Merkur Lekarski"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"E Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.24178","article-title":"Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice","volume":"53","author":"E Ramos","year":"2011","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.25746","article-title":"Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice","volume":"56","author":"Z Zhang","year":"2012","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"KF Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2006-02-003376","article-title":"Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis","volume":"108","author":"JC Lesbordes-Brion","year":"2006","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2012-07-440743","article-title":"Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis","volume":"120","author":"E Ramos","year":"2012","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.25615","article-title":"Inhibition of hepcidin transcription by growth factors","volume":"56","author":"JB Goodnough","year":"2012","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(95)06200-9","article-title":"Detection of iron-deficiency anemia in hospitalized patients by zinc protoporphyrin","volume":"244","author":"SS Wong","year":"1996","journal-title":"Clin Chim Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbrc.2003.12.096","article-title":"IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system","volume":"314","author":"K Hagihara","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"M Pak","year":"2006","journal-title":"Blood"},{"key":"ref29","unstructured":"Lynch EC (1990) Peripheral Blood Smear. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1054\/bjoc.2001.1750","article-title":"Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy","volume":"84","author":"GD Demetri","year":"2001","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group","volume":"16","author":"GD Demetri","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"H Ludwig","year":"2004","journal-title":"Eur J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","article-title":"Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group","volume":"15","author":"J Glaspy","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1634\/theoncologist.2009-S1-6","article-title":"Update on erythropoiesis-stimulating agents and clinical trials in oncology","volume":"14","author":"M Aapro","year":"2009","journal-title":"Oncologist"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.2009-S1-43","article-title":"Anemia management in oncology and hematology","volume":"14","author":"JL Spivak","year":"2009","journal-title":"Oncologist"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2010.151522","article-title":"A dual-monoclonal sandwich ELISA specific for hepcidin-25","volume":"56","author":"AM Butterfield","year":"2010","journal-title":"Clin Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1373\/clinchem.2008.121285","article-title":"Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients","volume":"55","author":"L Ukarma","year":"2009","journal-title":"Clin Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bcmd.2010.07.013","article-title":"Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI)","volume":"45","author":"BJ Sasu","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2013-08-521419","article-title":"A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin","volume":"123","author":"A Kim","year":"2014","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:32:46Z","timestamp":1565299966000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093283"}},"subtitle":[],"editor":[{"given":"Kostas","family":"Pantopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093283","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}